2,5-bis-(Glutathion-S-yl)-α-methyldopamine, a putative metabolite of (±)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations
- 4 April 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 323 (2-3) , 173-180
- https://doi.org/10.1016/s0014-2999(97)00044-7
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Effects of Intracerebroventricular Administration of 5-(Glutathion-S-yl)-α-methyldopamine on Brain Dopamine, Serotonin, and Norepinephrine Concentrations in Male Sprague-Dawley RatsChemical Research in Toxicology, 1996
- Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn‐superoxide dismutase transgenic miceSynapse, 1995
- Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicalsBrain Research, 1995
- Increasing Use of “Ecstasy“ (MDMA) and other Hallucinogens on a College CampusJournal of American College Health, 1994
- Modulatory Role of Glutathione on ?-Opioid, Substance P/Neurokinin-1, and Kainic Acid Receptor Binding SitesJournal of Neurochemistry, 1992
- Screening of Thiol Compounds: Depolarization‐Induced Release of Glutathione and Cysteine from Rat Brain SlicesJournal of Neurochemistry, 1992
- Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administrationBrain Research, 1988
- Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate CampusNew England Journal of Medicine, 1987
- MetabolicO-demethylation of 3,4-dimethoxy-amphetaminein vivoin dog and monkeyXenobiotica, 1979
- A facile one-step synthesis of cysteinyldopas using mushroom tyrosinaseCellular and Molecular Life Sciences, 1977